quintilesIMS Archives - Page 2 of 3 -

Cancer/ Clinical/ Quintiles - Oncol articles/ R&D/ Views and analysis

Innovations in cancer drug research

Richard Staines AstraZeneca, cancer, CAR T, clinical trial, ESMO, ESMO17, Immuno, Oncology, quintilesIMS, real world data, regulation 0 Comment

While cancer continues to be one of the leading causes of death and illness, new technology and increasing

Innovations in cancer drug research

https://pharmaphorum.com/views-and-analysis/innovations-cancer-drug-research/

Articles/ Healthcare/ UK & Europe/ Views and analysis

Will UK patients get access to novel drugs?

Andrew McConaghie NHS England, NICE, Quintiles IMS Market Access Summit, quintilesIMS, UK market access 0 Comment

Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.

Will UK patients get access to novel drugs?

https://pharmaphorum.com/views-and-analysis/will-uk-patients-get-access-to-novel-drugs/

T-cells attacking cancer cell illustration of microscopic photos

Oncology/ Partner Content/ Partner content/ Press releases/ Quintiles - ContentIO/ R&D

Beyond Immunotherapies

Julia Marsteller cancer, clinical trials, immunotherapy, pharma, quintilesIMS

Latest innovations emerging from immunotherapy research

Beyond Immunotherapies

https://pharmaphorum.com/partner-content-oncology/beyond-immunotherapies/

Oncology/ Partner Content/ Partner content/ Press releases/ Quintiles - ContentIO/ R&D

Managing Multi-Arm Studies in an Evolving Immuno-Oncology Landscape

Julia Marsteller cancer, clinical trials, immunotherapy, pharma, quintilesIMS

Collaborate with CROs and sites to help minimize risks

Managing Multi-Arm Studies in an Evolving Immuno-Oncology Landscape

https://pharmaphorum.com/partner-content-oncology/managing-multi-arm-studies-in-an-evolving-immuno-oncology-landscape-2/

Market Access/ Partner Content/ Pharma Market Access/ Press releases

Orphan medicines, advances, access and affordability

Adam Jeffery market access, NHS England, NICE, QALY, quintilesIMS, rare disease, STP, UK 0 Comment

LONDON, UNITED KINGDOM, April 19th 2017: The number of orphan drug candidates gaining European market authorisation has risen

Orphan medicines, advances, access and affordability

https://pharmaphorum.com/partner-content-market-access/orphan-medicines-advances-access-affordability/

Views and analysis

The top three benefits to commercial outsourcing in pharma

Craig Sharp commercial outsourcing, pharma, quintilesIMS 0 Comment

In the face of continuing industrial and technological progress – and the resulting imperative for business agility –

The top three benefits to commercial outsourcing in pharma

https://pharmaphorum.com/views-and-analysis/benefits-commercial-outsourcing-pharma/

Insights/ Sales and Marketing/ Whitepapers

Seizing the potential of commercial outsourcing in the pharmaceutical sector

Louise Bellamy commercial outsourcing, market access, pharma, quintilesIMS 0 Comment

The power and potential of outsourcing has long been recognised as a core enabler of business growth. Yet

Seizing the potential of commercial outsourcing in the pharmaceutical sector

https://pharmaphorum.com/whitepapers/seizing-potential-commercial-outsourcing-pharmaceutical-sector/

Articles/ Brexit/ Pharma Market Access/ R&D/ UK & Europe/ Views and analysis

Getting it right: the UK’s pathway for 2017

Linda Banks Brexit, European Patent Convention, HTA, market access, NICE, quintilesIMS, UK 0 Comment

The implications for global pharma HQs and what the UK needs to do.

Getting it right: the UK’s pathway for 2017

https://pharmaphorum.com/views-and-analysis/getting-right-uks-pathway-2017/

Insights/ Sales and Marketing/ Sales and Marketing/ Slider in whitepapers/ Whitepapers

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

Susan Wormald marketing, pharma, quintilesIMS 0 Comment

No longer are physicians the sole concern for the life sciences’ sales and marketing function. Today, as a

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

https://pharmaphorum.com/transversal-categories/sales-and-marketing/planning-executing-monitoring-three-pillars-effective-marketing-campaign/

Trending

quintilesIMS

Login